PCBL Chemical Ltd (PCBL)
🎯 Key Takeaways
- PCBL Chemical Ltd is in a transitional phase marked by governance changes and a strategic shift toward returning capital to shareholders despite modest financial recovery. The company declared a 450% interim dividend for FY2026-27, signaling confidence in near-term cash flows, while simultaneously undergoing board restructuring with the exit of an independent director and appointment of a new committee member.
- Revenue grew 19.7% QoQ to ₹2,473 in Q1FY27.
- ⚠️ Marginal improvement in operating margins has not translated into robust profitability, raising concerns about the sustainability of earnings growth.
- Market Cap
- ₹13,092
- P/E Ratio
- 50.1
- P/B Ratio
- 3.27
- ROE
- 6.5%
- ROCE
- 8.5%
- Debt/Equity
- 1.20
- Div Yield
- 1.80%
- Promoter
- 53.4%
📖 The Story
PCBL Chemical Ltd is in a transitional phase marked by governance changes and a strategic shift toward returning capital to shareholders despite modest financial recovery. The company declared a 450% interim dividend for FY2026-27, signaling confidence in near-term cash flows, while simultaneously undergoing board restructuring with the exit of an independent director and appointment of a new committee member. Revenue trends show sequential improvement from ₹1,846 crore in December 2025 to ₹2,473 crore in June 2026, but profitability remains pressured with operating margins expanding only marginally from 6.6% to 11.8% over the same period. The company’s financial trajectory reflects a recovery in top-line growth, yet returns on equity and capital are low at 6.5% and 8.5% respectively, indicating limited reinvestment efficiency.
📰 What's Happening
In the last two quarters, management has focused on financial engineering rather than operational expansion, highlighted by the board-approved 450% interim dividend (Rs. 4.50 per share) for FY2026-27, payable on 4 August 2026, following approval of unaudited Q1 FY2026 results on 29 July 2026. The board also executed governance updates, with Mr. R K Agarwal stepping down as Independent Director effective 25 July 2026 and Mr. Umang Kanoria appointed to the Audit Committee. These actions align with SEBI compliance and suggest continuity in governance oversight. The company disclosed security cover for debentures linked to Aquapharm Chemical shares, indicating potential collateral arrangements tied to strategic investments or financing.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 2,164 | 1,846 | 2,066 | 2,473 |
| Operating Profit | 173 | 121 | 149 | 292 |
| OPM % | 8.0% | 6.6% | 7.2% | 11.8% |
| Net Profit | 62 | 2 | 40 | 155 |
| EPS | ₹1.63 | ₹0.05 | ₹1.02 | ₹3.94 |
The company’s financial trajectory shows a clear recovery in revenue and profitability from the lows of December 2025, with June 2026 revenue up 34% year-on-year and operating profit margin expanding to 11.8% from 6.6% in December 2025. However, net profit remains volatile, with a sharp rise to ₹155 crore in June 2026 from ₹40 crore in March 2026, suggesting seasonality or one-time gains. Despite this, return ratios remain subdued, with ROE at 6.5% and ROCE at 8.5%, implying that growth is not yet translating into high capital efficiency. The financial performance supports management’s confidence in cash flow generation, as evidenced by the dividend declaration, but does not yet indicate a sustainable earnings recovery.
🔮 Management Outlook & What's Next
Management has not provided forward-looking guidance on revenue, margins, or capital allocation beyond the interim dividend declaration and record date announcement. The filings do not include earnings forecasts, long-term targets, or strategic roadmaps. The only explicit forward-looking element is the fixed record date for dividend payment on 4 August 2026, which signals near-term liquidity planning. Absent formal guidance, investor focus will remain on execution of operational improvements and whether future dividends can be sustained without diluting equity or increasing leverage.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 38 | 38 | 39 | 38 |
| Reserves | 3,660 | 3,776 | 3,967 | 3,833 |
| Borrowings | 5,571 | 4,906 | 4,825 | 5,252 |
| Total Liabilities | 11,722 | 11,745 | 11,295 | 11,686 |
| Fixed Assets | 3,784 | 3,626 | 7,141 | 3,982 |
| Investments | 516 | 672 | 469 | 515 |
| Total Assets | 11,722 | 11,745 | 11,295 | 11,686 |
The balance sheet shows a stable capital structure with equity remaining flat at approximately ₹38–39 crore over the past two fiscal years, while reserves have grown from ₹3,660 crore to ₹3,967 crore, indicating retained earnings accumulation. Borrowings have slightly decreased from ₹5,571 crore to ₹4,825 crore, suggesting active deleveraging or reduction in short-term obligations. Total assets have declined marginally from ₹11,722 crore to ₹11,295 crore, reflecting asset sales or revaluation. This pattern indicates conservative capital management, with a preference for preserving financial stability over aggressive expansion, consistent with a firm prioritizing dividend sustainability over reinvestment.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | +760 | +1,576 |
| Investing | -690 | -675 |
| Financing | -64 | -990 |
| Net Cash Flow | +6 | -89 |
👥 Shareholding Pattern
| Category | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|
| Promoters | 53.4% | 53.4% | 53.4% |
| FII | 5.7% | 5.6% | 5.8% |
| DII | 10.2% | 11.0% | 11.3% |
| Public | 23.0% | 22.7% | 22.1% |
| # Shareholders | 2,81,584 | 2,84,488 | 2,75,244 |
Shareholding patterns show stable promoter holding at 53.38% over the last three quarters, with minor fluctuations in FII and DII participation. FII holdings have slightly declined from 5.68% to 5.79% in Q1FY27, while DII increased from 10.19% to 11.27%, suggesting institutional accumulation among DII investors. The number of public shareholders has risen from 2,75,244 to 2,84,488, indicating retail investor engagement. No significant dilution or pledging is evident, and the consistent promoter stake supports governance continuity. The modest rise in DII and public shareholding may reflect growing confidence among institutional and retail investors despite broader market weakness.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.53 L Cr | 57.6 | 33.4% | — | 0.01 |
| SRF | 73,810 | 34.1 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,814 | 96.7 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,774 | 79.7 | 9.6% | — | 0.34 |
| NAVINFLUOR | 43,256 | 54.7 | 22.2% | — | 0.31 |
| GODREJIND | 36,153 | 30.8 | 9.2% | — | 4.57 |
| HSCL | 33,807 | 42.0 | 20.7% | — | 0.16 |
| AETHER | 23,029 | 97.7 | 13.8% | — | 0.08 |
| DEEPAKNTR | 21,155 | 27.0 | 15.3% | — | 0.26 |
| CASTROLIND | 19,891 | 18.7 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Marginal improvement in operating margins has not translated into robust profitability, raising concerns about the sustainability of earnings growth. 2. High debt levels relative to equity (D/E of 1.20) combined with low ROCE (8.5%) suggest limited capital efficiency, increasing vulnerability to margin compression. 3. The company’s ability to sustain a 450% interim dividend without corresponding earnings growth or asset monetization poses a financial risk, especially given negative net cash flow in recent quarters. 4. Governance changes, while routine, may introduce execution risks if new committee members lack operational or sectoral expertise, potentially affecting oversight of strategic decisions.
📋 Recent Filings
- 🟡 Board Meeting2026-09-25PCBL Chemical held its 65th AGM on September 22, 2026 via video conference, with 129 members attending. Chairman Dr. Sanjiv Goenka highlighted ongoing…
- share transfer2026-09-24PCBL Chemical Ltd re-lodged transfer requests for physical shares in August 2026, reporting 24 pending and 1 resolved transfer, with no material chang…
- Announcement2026-09-23PCBL Chemical Ltd announced that its trading window will close on 1 October 2026, remaining shut for 48 hours after the unaudited quarterly results fo…
- 🟡 Board Meeting2026-09-22PCBL announced the retirement of Company Secretary Kaushik Mukherjee effective 30 September 2026 and appointed Ravi Varma as his successor effective 1…
- 🟡 Board Meeting2026-09-22PCBL Chemical held its 65th AGM on 22 September 2026 via video conference, with 129 shareholders attending, including 6 via proxy. All four resolution…
- 🟡 voting results2026-09-22PCBL Chemical held its 65th AGM on September 22, 2026 via video conference, with 129 shareholders attending, including 6 via proxy. All four resolutio…
- 🟡 Board Meeting2026-09-22PCBL announced the retirement of Kaushik Mukherjee as Company Secretary and Compliance Officer effective 30 September 2026, and appointed Ravi Varma a…
- 🔴 Announcement2026-09-18PCBL Chemical Ltd announced it will participate in the PL Capital Investor Conference on September 29, 2026, at a physical venue in Mumbai, inviting i…
- 🔴 Announcement2026-09-18PCBL Chemical disclosed an ESG rating of 68.86 from Niche99 ESG Ratings, categorized as 'Leader', based on public disclosures. The rating was assigned…
- 🔴 Announcement2026-09-17PCBL Chemical disclosed its ESG ratings from Crisil ESG Ratings & Analytics Ltd, receiving an overall score of Crisil ESG 61 and a Core ESG rating of …
🧠 Analyst's Read
The company is navigating a delicate phase where financial recovery is emerging but not yet durable, and capital returns are being prioritized amid modest operational gains. Investors should monitor whether the current revenue and margin trends can sustain dividend policy without increasing leverage or asset sales, and assess the impact of governance changes on strategic oversight. The next key catalyst will be the Q2 FY2026 results and management’s commentary on demand trends in the chemical sector.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-29.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when PCBL files new disclosures
Track PCBL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track PCBL — FreeFree account · 2 AI queries/day